MedTrace Logo

Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer

NCT00816244 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2012-04-13

No results posted yet for this study

Summary

The purpose of this study is to monitor:

* Tumor biological alterations following two weeks of neo-adjuvant statin therapy.
* Effects of statins on tumor proliferation.
* Functional studies on the mevalonate pathway.

Conditions

Interventions

DRUG

Atorvastatin

Atorvastatin 80 mg daily for two weeks, ending at the day of operation for breast cancer.

Sponsors & Collaborators

  • Lund University Hospital

    lead OTHER

Principal Investigators

  • Carsten Rose, MD · University Hospital Lund

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00816244 on ClinicalTrials.gov